This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
(Updates from 10:45 a.m. ET with closing information.)
NEW YORK (
TheStreet) -- Here's what Jim Cramer had to say on
CNBC's "Squawk on the Street" Wednesday.
A new cholesterol drug from
Regeneron Pharmaceuticals(REGN - Get Report) had very positive phase III results and Cramer said it's putting
Merck's(MRK) Zetia drug to shame. REGN jumped 6% to $17.22.
Kroger(KR - Get Report) with a neutral rating. Cramer said he prefers
Whole Foods Market(WFM). KR rose 1% to $41.87.
"Goldman Sachs blesses"
American Tower(AMT - Get Report) by reiterating it as a buy, Cramer said, adding that the last thing we heard about the company involved accounting issues. AMT was 3.2% higher at $77.12.
Deutsche Bank raised its price target on
Cheniere Energy(LNG - Get Report). Even though the stock has quadrupled in value, it appears to still have upside, according to Cramer. LNG was up 3.5% on the day to $38.17.
Stanley Black & Decker(SWK - Get Report) provided dismal guidance and had poor margins, said Cramer. "This is a disaster." SWK plummeted 14.3% to $76.75.
Abbott Laboratories(ABT - Get Report) beat earnings estimates and raised its dividend. Cramer thinks CEO Miles White is going great things and likes the dividend. ABT jumped 6.5% to $35.90.
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.-- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell